Related Experiment Video

Updated: Dec 12, 2025

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.9K

Personalized medicine for cardiovascular diseases

Hayato Tada1, Noboru Fujino2, Akihiro Nomura2

  • 1Department of Cardiovascular Medicine, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan. ht240z@sa3.so-net.ne.jp.

Journal of Human Genetics
|August 11, 2020
PubMed

Insights

Personalized medicine uses genetic information to predict cardiovascular disease risk and guide tailored treatments. This approach benefits both rare and common conditions, improving patient health outcomes.

Area of Science:

  • Genetics
  • Cardiology
  • Personalized Medicine

Background:

  • Cardiovascular diseases have heritable components, making family history crucial for risk prediction.
  • Genetic information, specifically germline mutations, can enhance cardiovascular disease risk assessment.
  • Individual genetic makeup influences treatment effectiveness and preventive strategies.

Purpose of the Study:

  • To define personalized medicine in the context of human genetics for cardiovascular diseases.
  • To provide examples of personalized medicine applications for coronary artery disease, arrhythmia, and cardiomyopathies.
  • To highlight the role of Mendelian randomization studies in identifying high-risk individuals and therapeutic targets.

Main Methods:

  • Review of current literature on personalized medicine and cardiovascular genetics.
  • Focus on Mendelian randomization studies, particularly those involving loss-of-function genetic variations.
  • Analysis of signaling pathways relevant to cardiovascular health and disease prevention.

Main Results:

  • Genetic data aids in predicting susceptibility to cardiovascular diseases.
  • Personalized medicine strategies can be developed based on individual genotypes for cardiovascular conditions.
  • Mendelian randomization studies identify genetic factors influencing cardiovascular risk and potential therapeutic targets.

Conclusions:

  • Personalized medicine, guided by human genetics, offers a powerful approach to managing cardiovascular diseases.
  • Identifying genetic predispositions allows for targeted prevention and treatment strategies.
  • Further research into genetic variations and signaling pathways can optimize cardiovascular health.

More Related Videos

In Silico Clinical Trials for Cardiovascular Disease09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.1K
Development and Evaluation of 3D-Printed Cardiovascular Phantoms for Interventional Planning and Training09:57

Development and Evaluation of 3D-Printed Cardiovascular Phantoms for Interventional Planning and Training

Published on: January 18, 2021

4.4K

Related Concept Videos

Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
3.8K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.7K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
250
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
512
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
655
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
190